Our CSO, Jesse Boehm, delivers the closing keynote at #slas2025 today—reflecting on a decade of lab science innovation, the power of collaboration in cancer research, and sharing Break Through Cancer’s vision SLAS slas.org/events-calenda…

Today our CSO, Jesse Boehm, joins the “From Bench to Bedside: Rare Cancer Innovations” panel at The Boston Globe Rare Disease Summit 2025. If you're at the event, be sure to check out this important discussion Boston Globe Events rarediseasesummit2025.splashthat.com

This #InternationalWomensDay we’re spotlighting some of the women leading the charge in cancer research that we are proud to support. Their expertise and leadership drive #RadicalCollaboration in oncology. Meet them below! #WomeninSTEM #IWD2025

Dr. Nilofer Azad’s (Johns Hopkins Kimmel Cancer Center) work combining targeted and immunotherapies as well as cancer vaccines is shaping the future of drug development as part of our Demystifying Pancreatic Cancer Therapies TeamLab #WomeninSTEM #IWD2025 #RadicalCollaboration

Dr. Stephanie Dougan’s (Dana-Farber) is advancing immunotherapy with our Conquering KRAS and Demystifying Pancreatic Cancer Therapies TeamLabs—using the immune system to fight cancer #WomeninSTEM #IWD2025 #RadicalCollaboration

Dr. Zuzana Tothova (Dana-Farber) is uncovering how epigenetic changes drive clonal hematopoiesis and myeloid malignancies. In our Targeting Clonal Hematopoiesis to Prevent AML TeamLab, she’s shaping strategies to prevent and treat AML. #WomeninSTEM #IWD2025 #RadicalCollaboration

Dr. Natalie Vokes (Natalie Vokes, MD Anderson Cancer Center) is using cancer genomics to uncover predictors of therapy response and resistance. With our PoweRD 2 Cure ALK+ Lung Cancer TeamLab, she is advancing precision medicine for lung cancer. #WomeninSTEM #IWD2025 #RadicalCollaboration

Dr. Adrienne Boire (Memorial Sloan Kettering Cancer Center) studies how cancer adapts to the leptomeningeal space and using spinal fluid to better understand CNS malignancies. With our Accelerating GBM Therapies Through Serial Biopsies TeamLab, she’s transforming GBM research. #WomeninSTEM #IWD2025

Dr. Duaa Al-Rawi (Memorial Sloan Kettering Cancer Center) is detecting and modeling early invasive ovarian cancer, by studying serous tubal intraepithelial carcinoma (STIC) lesions using single-cell sequencing and spatial transcriptomics. With our Intercepting Ovarian Cancer TeamLab her work is

Dr. Linghua Wang (Linghua Wang, MD, PhD, MD Anderson Cancer Center) leads a computational biology lab, using single-cell and spatial omics to unravel tumor complexity—advancing cancer research with bioinformatics. As a leader in our Data Science TeamLab, she exemplifies #RadicalCollaboration—working

Dr. Jacqueline S. Garcia (Dana-Farber) is finding vulnerabilities in resistant AML to better understand targeted therapies. With our Eradicating Minimal Residual Disease in AML TeamLab, she is advancing new strategies to outsmart resistant AML. #WomeninSTEM #IWD2025

Dr. Paula Hammond’s (Koch Institute at MIT) groundbreaking work in nanotechnology has transformed drug delivery and materials science, exemplified by her decorated career. Just as important is her leadership—shaping the next generation of scientists through mentorship. Captured in this

Deeply grateful for the support from Break Through Cancer and for being included in this #InternationalWomensDay spotlight! I’m proud to collaborate with brilliant minds in oncology, biology, immunology, and data science. MD Anderson Cancer Center #RadicalCollaboration #WomeninSTEM #IWD2025

Benjamin D. Hopkins, Jesse S. Boehm, and Peter Horak discussed "Functional and Genomic Precision Medicine in Solid Tumors" in a plenary session at the AACR Special Conference on Functional and Genomic Precision Medicine in Cancer. #AACRprecmed25 Jesse Boehm

There is an increased need for fresh desmoid tumor tissue samples for research. If you have a desmoid patient considering surgery, please inform them of our tissue donation program. Online consent prior to surgery via pattern.org is required. dtrf.org/donate-tissue-…

Is it possible to prevent leukemia? Just launched—an exploratory trial aimed to assess if we can prevent AML in high-risk patients. Learn how we’re giving patients the option to move from “wait and see” to early intervention here: prnewswire.com/news-releases/… #CancerPrevention

We are collaborating with American Cancer Society to raise awareness and advance efforts to prevent ovarian cancer—one of the leading causes of cancer deaths among women. breakthroughcancer.org/2025/09/outsma…

What a great partner to drive discovery into the clinic to “Outsmart Ovarian Cancer” and save lives.

The AACR congratulates Anthony Letai, MD, PhD, on his appointment as the 18th Director of the National Cancer Institute. We look forward to working with Dr. Letai and the NCI to advance our shared mission to prevent and cure all cancers. brnw.ch/21wWcA1 National Cancer Institute

New in nature Led by Sohrab Shah and Marc Williams this Break Through Cancer–supported study unveils a blood-based technology to track ovarian cancer over time, revealing hidden drug-resistant cells and pointing to new treatment opportunities. More: breakthroughcancer.org/2025/10/new-bl…